The SFDA reported that it has built a stockpile of human bird flu vaccine, though it did not disclose the size of the stockpile. The vaccine, a whole virus product called Panflu, was produced by Sinovac Biotech Co., Ltd. (北京科兴生物制品有限公司). Previously, the SFDA approved Panflu for humans aged 18 to 60 as a protective vaccine against the H5N1 virus. More details...

Stock Symbol:  (NYSE Alternext US: SVA)